{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T00:23:01Z","timestamp":1760746981678,"version":"build-2065373602"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T00:00:00Z","timestamp":1760659200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T00:00:00Z","timestamp":1760659200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100010663","name":"H2020 European Research Council","doi-asserted-by":"publisher","award":["865792"],"award-info":[{"award-number":["865792"]}],"id":[{"id":"10.13039\/100010663","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Trials"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Whilst women with diabetes are at risk of having a pregnancy complicated by foetal macrosomia, a small but important minority of women develop placental dysfunction leading to a small for gestational age infant (SGA\u2009&lt;\u200910th centile) (20%) and\/or the development of pre-eclampsia (12\u201318%) which may in some cases require preterm birth. In the UK, currently, metformin is offered as first line to treat diabetes during pregnancy, regardless of the risk of placental disease; however, the effect of metformin on placental function and foetal growth remains unclear. Metformin Impact on Maternal and Infant Cardiometabolic Health (MIMICH) and Metformin Impact on Maternal and Infant Cardiometabolic Health After Pregnancy (MIMICH II) aim to better understand the impact of metformin in the context of pregnancies at high risk of placental disease by evaluating the effect of metformin on foetal growth, placental function and maternal and infant cardiometabolic health.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>MIMICH is a randomised control trial (RCT) comparing routine treatment for diabetes, the standard of care, to withholding metformin (the intervention) during pregnancy, in women with type 2 diabetes or gestational diabetes (GDM) who have maternal or uteroplacental risk factors for placental disease in a target sample of 225 participants. Participants receive the recommended schedule of antenatal care, including serial biometry ultrasound with the addition of fractional thigh volume measurement. The primary outcome will be change in estimated weight z-score from second trimester to birth. The MIMICH II study will follow up the mothers and infants at 3\u20136 months and 12\u201315 months after pregnancy. Study procedures include anthropometric measurements from both mother and baby, data collection about medications, complications after birth and feeding, and maternal blood sampling. Infant echocardiography, blood pressure measurements and venepuncture will also be undertaken where possible.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Discussion<\/jats:title>\n            <jats:p>Previous studies investigating hypoglycaemic agents in pregnancy have used birthweight as the primary outcome. In pregnancies where there are conflicting exposures influencing foetal growth and placental function (e.g. hypertension and hyperglycaemia), absolute birthweight is not sufficient to detect subtle, but clinically significant changes in foetal growth and placental function. To address this limitation, longitudinal measures of foetal growth will be used to quantify the deviation in foetal growth trajectory in the third trimester, using comparison with foetal growth prediction based on second trimester biometry from the same foetus.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Trial registration<\/jats:title>\n            <jats:p>ISRCTN13866189. Registered on February 15, 2021.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/s13063-025-09154-5","type":"journal-article","created":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T13:21:50Z","timestamp":1760707310000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Metformin Impact on Maternal and Infant Cardiometabolic Health (MIMICH), an open-label randomised controlled trial, and Metformin Impact on Maternal and Cardiometabolic Health After Pregnancy (MIMICH II)"],"prefix":"10.1186","volume":"26","author":[{"given":"Anya","family":"Amica-Carpenter","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-3512-1486","authenticated-orcid":false,"given":"David Richard","family":"Cox","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yvonne","family":"Sylvestre","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephen A.","family":"Roberts","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Reena","family":"Perchard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eleasha","family":"Calloway","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kerrie","family":"Richardson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jenny","family":"Myers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,10,17]]},"reference":[{"issue":"Jul 1;","key":"9154_CR1","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/j.diabres.2017.03.030","volume":"129","author":"CE Eades","year":"2017","unstructured":"Eades CE, Cameron DM, Evans JMM. Prevalence of gestational diabetes mellitus in Europe: a meta-analysis. Diabetes Res Clin Pract. 2017;129(Jul 1;):173\u201381.","journal-title":"Diabetes Res Clin Pract"},{"key":"9154_CR2","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2015-009494","author":"SJ Coton","year":"2016","unstructured":"Coton SJ, Nazareth I, Petersen I. A cohort study of trends in the prevalence of pregestational diabetes in pregnancy recorded in UK general practice between 1995 and 2012. BMJ Open. 2016. https:\/\/doi.org\/10.1136\/bmjopen-2015-009494.","journal-title":"BMJ Open"},{"issue":"10","key":"9154_CR3","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1093\/aje\/kwx263","volume":"186","author":"R Pace","year":"2017","unstructured":"Pace R, Brazeau AS, Meltzer S, Rahme E, Dasgupta K. Conjoint associations of gestational diabetes and hypertension with diabetes, hypertension, and cardiovascular disease in parents: a retrospective cohort study. Am J Epidemiol. 2017Nov 15;186(10):1115\u201324.","journal-title":"Am J Epidemiol"},{"key":"9154_CR4","doi-asserted-by":"crossref","unstructured":"Omori Y, Minei S, Testuo T, Nemoto K, Shimizu M, Sanaka M. Current status of pregnancy in diabetic women. A comparison of pregnancy in IDDM and NIDDM mothers. Diabetes Res Clin Pract. 1994;24:S273\u20138.","DOI":"10.1016\/0168-8227(94)90261-5"},{"issue":"11","key":"9154_CR5","doi-asserted-by":"publisher","first-page":"1229","DOI":"10.1111\/j.1464-5491.2007.02254.x","volume":"24","author":"C Howarth","year":"2007","unstructured":"Howarth C, Gazis A, James D. Associations of type 1 diabetes mellitus, maternal vascular disease and complications of pregnancy. Diabet Med. 2007;24(11):1229\u201334.","journal-title":"Diabet Med"},{"issue":"9","key":"9154_CR6","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1111\/jpc.13593","volume":"53","author":"AZ Khambalia","year":"2017","unstructured":"Khambalia AZ, Algert CS, Bowen JR, Collie RJ, Roberts CL. Long-term outcomes for large for gestational age infants born at term. J Paediatr Child Health. 2017Sep 1;53(9):876\u201381.","journal-title":"J Paediatr Child Health"},{"key":"9154_CR7","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajog.2014.04.021","author":"AS Trudell","year":"2014","unstructured":"Trudell AS, Tuuli MG, Cahill AG, Macones GA, Odibo AO. Balancing the risks of stillbirth and neonatal death in the early preterm small-for-gestational-age fetus. Am J Obstet Gynecol. 2014. https:\/\/doi.org\/10.1016\/j.ajog.2014.04.021.","journal-title":"Am J Obstet Gynecol"},{"issue":"Suppl 1","key":"9154_CR8","doi-asserted-by":"publisher","first-page":"A134.1-A134","DOI":"10.1136\/archdischild-2014-306576.390","volume":"99","author":"L Stirrat","year":"2014","unstructured":"Stirrat L, Denison F, Love C, Lindsay R, Reynolds R. PMM.34 screening and management of gestational diabetes mellitus in Scottish units: a national survey. Arch Dis Child Fetal Neonatal Ed. 2014;99(Suppl 1):A134.1-A134.","journal-title":"Arch Dis Child Fetal Neonatal Ed"},{"key":"9154_CR9","unstructured":"NICE. NICE diabetes in pregnancy [Internet]. 2023. Available from: https:\/\/www.nice.org.uk\/"},{"issue":"4","key":"9154_CR10","doi-asserted-by":"publisher","first-page":"367.e1","DOI":"10.1016\/j.ajog.2018.06.013","volume":"219","author":"LA Barbour","year":"2018","unstructured":"Barbour LA, Scifres C, Valent AM, Friedman JE, Buchanan TA, Coustan D, et al. A cautionary response to SMFM statement: pharmacological treatment of gestational diabetes. Am J Obstet Gynecol. 2018Oct 1;219(4):367.e1-367.e7.","journal-title":"Am J Obstet Gynecol"},{"issue":"10","key":"9154_CR11","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1016\/S2213-8587(20)30310-7","volume":"8","author":"DS Feig","year":"2020","unstructured":"Feig DS, Donovan LE, Zinman B, Sanchez JJ, Asztalos E, Ryan EA, et al. Metformin in women with type 2 diabetes in pregnancy (MiTy): a multicentre, international, randomised, placebo-controlled trial. Lancet Diabetes Endocrinol. 2020Oct 1;8(10):834\u201344.","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"5","key":"9154_CR12","doi-asserted-by":"publisher","first-page":"517.e1","DOI":"10.1016\/j.ajog.2021.04.229","volume":"225","author":"MJ Pic\u00f3n-C\u00e9sar","year":"2021","unstructured":"Pic\u00f3n-C\u00e9sar MJ, Molina-Vega M, Su\u00e1rez-Arana M, Gonz\u00e1lez-Mesa E, Sola-Moyano AP, Roldan-L\u00f3pez R, et al. Metformin for gestational diabetes study: metformin vs insulin in gestational diabetes: glycemic control and obstetrical and perinatal outcomes: randomized prospective trial. Am J Obstet Gynecol. 2021Nov 1;225(5):517.e1-517.e17.","journal-title":"Am J Obstet Gynecol"},{"key":"9154_CR13","doi-asserted-by":"publisher","DOI":"10.1080\/14767058.2023.2295809","author":"R Wu","year":"2024","unstructured":"Wu R, Zhang Q, Li Z. A meta-analysis of metformin and insulin on maternal outcome and neonatal outcome in patients with gestational diabetes mellitus. J Matern Fetal Neonatal Med. 2024. https:\/\/doi.org\/10.1080\/14767058.2023.2295809.","journal-title":"J Matern Fetal Neonatal Med"},{"issue":"1","key":"9154_CR14","doi-asserted-by":"publisher","first-page":"S21","DOI":"10.1016\/j.ajog.2023.11.042","volume":"230","author":"KM Aagaard","year":"2024","unstructured":"Aagaard KM, Kievit P, Gannon M, McCurdy C, Wesolowski S, Friedman J, et al. 25 initiation of metformin in pregnancy results in fetal bioaccumulation, growth restriction & renal dysmorphology. Am J Obstet Gynecol. 2024Jan;230(1):S21.","journal-title":"Am J Obstet Gynecol"},{"issue":"3","key":"9154_CR15","doi-asserted-by":"publisher","first-page":"356.e1","DOI":"10.1016\/j.ajog.2015.12.019","volume":"214","author":"FC Brownfoot","year":"2016","unstructured":"Brownfoot FC, Hastie R, Hannan NJ, Cannon P, Tuohey L, Parry LJ, et al. Metformin as a prevention and treatment for preeclampsia: effects on soluble fms-like tyrosine kinase 1 and soluble endoglin secretion and endothelial dysfunction. Am J Obstet Gynecol. 2016Mar 1;214(3):356.e1-356.e15.","journal-title":"Am J Obstet Gynecol"},{"issue":"1","key":"9154_CR16","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/2049-3002-2-12","volume":"2","author":"S Andrzejewski","year":"2014","unstructured":"Andrzejewski S, Gravel SP, Pollak M, St-Pierre J. Metformin directly acts on mitochondria to alter cellular bioenergetics. Cancer Metab. 2014;2(1):12.","journal-title":"Cancer Metab"},{"issue":"7506","key":"9154_CR17","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1038\/nature13270","volume":"510","author":"AK Madiraju","year":"2014","unstructured":"Madiraju AK, Erion DM, Rahimi Y, Zhang XM, Braddock DT, Albright RA, et al. Metformin suppresses gluconeogenesis by inhibiting mitochondrial glycerophosphate dehydrogenase. Nature. 2014;510(7506):542\u20136.","journal-title":"Nature"},{"key":"9154_CR18","doi-asserted-by":"crossref","unstructured":"Luengo A, Sullivan LB, Heiden VGV. Understanding the complex-I-ty of metformin action: limiting mitochondrial respiration to improve cancer therapy. BMC Biol. 2014;12(1).","DOI":"10.1186\/s12915-014-0082-4"},{"issue":"2","key":"9154_CR19","doi-asserted-by":"publisher","first-page":"989","DOI":"10.3390\/ijms23020989","volume":"23","author":"S Liu","year":"2022","unstructured":"Liu S, Washio J, Sato S, Abiko Y, Shinohara Y, Kobayashi Y, et al. Rewired cellular metabolic profiles in response to metformin under different oxygen and nutrient conditions. Int J Mol Sci. 2022;23(2):989.","journal-title":"Int J Mol Sci"},{"issue":"6","key":"9154_CR20","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.1161\/01.HYP.0000221429.94591.72","volume":"47","author":"Y Hattori","year":"2006","unstructured":"Hattori Y, Suzuki K, Hattori S, Kasai K. Metformin inhibits cytokine-induced nuclear factor \u03bab activation via AMP-activated protein kinase activation in vascular endothelial cells. Hypertension. 2006;47(6):1183\u20138.","journal-title":"Hypertension"},{"issue":"8","key":"9154_CR21","doi-asserted-by":"publisher","first-page":"3943","DOI":"10.1210\/jc.2004-0019","volume":"89","author":"AE Caballero","year":"2004","unstructured":"Caballero AE, Delgado A, Aguilar-Salinas CA, Herrera AN, Castillo JL, Cabrera T, et al. The differential effects of metformin on markers of endothelial activation and inflammation in subjects with impaired glucose tolerance: a placebo-controlled, randomized clinical trial. J Clin Endocrinol Metab. 2004;89(8):3943\u20138.","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"9154_CR22","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1111\/aji.12339","volume":"73","author":"CS Han","year":"2015","unstructured":"Han CS, Herrin MA, Pitruzzello MC, Mulla MJ, Werner EF, Pettker CM, et al. Glucose and metformin modulate human first trimester trophoblast function: a model and potential therapy for diabetes-associated uteroplacental insufficiency. Am J Reprod Immunol. 2015Apr 1;73(4):362\u201371.","journal-title":"Am J Reprod Immunol"},{"issue":"19","key":"9154_CR23","doi-asserted-by":"publisher","first-page":"2003","DOI":"10.1056\/NEJMoa0707193","volume":"358","author":"JA Rowan","year":"2008","unstructured":"Rowan JA, Hague WM, Gao W, Battin MR, Moore MP. Metformin versus insulin for the treatment of gestational diabetes. N Engl J Med. 2008;358(19):2003\u201315.","journal-title":"N Engl J Med"},{"issue":"5","key":"9154_CR24","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1056\/NEJMoa1509819","volume":"374","author":"A Syngelaki","year":"2016","unstructured":"Syngelaki A, Nicolaides KH, Balani J, Hyer S, Akolekar R, Kotecha R, et al. Metformin versus placebo in obese pregnant women without diabetes mellitus. N Engl J Med. 2016;374(5):434\u201343.","journal-title":"N Engl J Med"},{"issue":"11","key":"9154_CR25","first-page":"CD012037","volume":"11","author":"J Brown","year":"2017","unstructured":"Brown J, Grzeskowiak L, Williamson K, Downie MR, Crowther CA. Insulin for the treatment of women with gestational diabetes. Cochrane Database Syst Rev. 2017;11(11):CD012037.","journal-title":"Cochrane Database Syst Rev"},{"key":"9154_CR26","doi-asserted-by":"crossref","unstructured":"Silva VB, Fonseca L, Pereira MT, Vilaverde J, Pinto C, Pichel F, et al. Predictors of metformin monotherapy failure in gestational diabetes mellitus. Endocr Connect. 2022;11(5).","DOI":"10.1530\/EC-21-0540"},{"issue":"1","key":"9154_CR27","doi-asserted-by":"publisher","first-page":"5745","DOI":"10.1038\/s41598-018-23965-4","volume":"8","author":"BE Gregg","year":"2018","unstructured":"Gregg BE, Botezatu N, Brill JD, Hafner H, Vadrevu S, Satin LS, et al. Gestational exposure to metformin programs improved glucose tolerance and insulin secretion in adult male mouse offspring. Sci Rep. 2018;8(1):5745\u2013811.","journal-title":"Sci Rep"},{"key":"9154_CR28","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0056594","author":"H Salom\u00e4ki","year":"2013","unstructured":"Salom\u00e4ki H, V\u00e4h\u00e4talo LH, Laurila K, J\u00e4ppinen NT, Penttinen AM, Ailanen L, et al. Prenatal metformin exposure in mice programs the metabolic phenotype of the offspring during a high fat diet at adulthood. PLoS ONE. 2013. https:\/\/doi.org\/10.1371\/journal.pone.0056594.","journal-title":"PLoS ONE"},{"issue":"5","key":"9154_CR29","doi-asserted-by":"publisher","first-page":"e1222","DOI":"10.1542\/peds.2012-0346","volume":"130","author":"SM Carlsen","year":"2012","unstructured":"Carlsen SM, Martinussen MP, Vanky E. Metformin\u2019s effect on first-year weight gain: a follow-up study. Pediatrics (Evanston). 2012;130(5):e1222\u20136.","journal-title":"Pediatrics (Evanston)"},{"issue":"7","key":"9154_CR30","doi-asserted-by":"publisher","first-page":"994","DOI":"10.1111\/1471-0528.12964","volume":"122","author":"H Ij\u00e4s","year":"2015","unstructured":"Ij\u00e4s H, V\u00e4\u00e4r\u00e4sm\u00e4ki M, Saarela T, Keravuo R, Raudaskoski T. A follow-up of a randomised study of metformin and insulin in gestational diabetes mellitus: growth and development of the children at the age of 18 months. BJOG. 2015;122(7):994.","journal-title":"BJOG"},{"issue":"10","key":"9154_CR31","doi-asserted-by":"publisher","first-page":"2279","DOI":"10.2337\/dc11-0660","volume":"34","author":"JA Rowan","year":"2011","unstructured":"Rowan JA, Rush EC, Obolonkin V, Battin M, Wouldes T, Hague WM. Metformin in gestational diabetes: the offspring follow-up (MiG TOFU) - body composition at 2 years of age. Diabetes Care. 2011;34(10):2279\u201384.","journal-title":"Diabetes Care"},{"key":"9154_CR32","doi-asserted-by":"crossref","unstructured":"Rowan JA, Rush EC, Plank LD, Lu J, Obolonkin V, Coat S, et al. Metformin in gestational diabetes: the offspring follow-up (MiG TOFU): body composition and metabolic outcomes at 7\u20139 years of age. BMJ Open Diabetes Res Care. 2018;6(1).","DOI":"10.1136\/bmjdrc-2017-000456"},{"key":"9154_CR33","unstructured":"van Weelden Vincent Wekker Leon de Wit Jacqueline Limpens Hilkka Ij\u00e4s Aleid van Wassenaer-Leemhuis Tessa J Roseboom Bas B van Rijn J Hans DeVries Rebecca C Painter WG. Long-term effects of oral antidiabetic drugs during pregnancy on offspring: a systematic review and meta-analysis of follow-up studies of RCTs. Available from: https:\/\/doi.org\/10.6084\/"},{"issue":"3","key":"9154_CR34","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/S2213-8587(23)00004-9","volume":"11","author":"DS Feig","year":"2023","unstructured":"Feig DS, Sanchez JJ, Murphy KE, Asztalos E, Zinman B, Simmons D, et al. Outcomes in children of women with type 2 diabetes exposed to metformin versus placebo during pregnancy (MiTy Kids): a 24-month follow-up of the MiTy randomised controlled trial. Lancet Diabetes Endocrinol. 2023Mar 1;11(3):191\u2013202.","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"7240","key":"9154_CR35","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1136\/bmj.320.7240.967","volume":"320","author":"KKL Ong","year":"2000","unstructured":"Ong KKL, Ahmed ML, Dunger DB, Emmett PM, Preece MA. Association between postnatal catch-up growth and obesity in childhood: prospective cohort study. Br Med J. 2000Apr 8;320(7240):967\u201371.","journal-title":"Br Med J"},{"issue":"2","key":"9154_CR36","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1161\/CIRCULATIONAHA.106.617811","volume":"115","author":"A Singhal","year":"2007","unstructured":"Singhal A, Cole TJ, Fewtrell M, Kennedy K, Stephenson T, Elias-Jones A, et al. Promotion of faster weight gain in infants born small for gestational age: is there an adverse effect on later blood pressure? Circulation. 2007;115(2):213\u201320.","journal-title":"Circulation"},{"issue":"21","key":"9154_CR37","doi-asserted-by":"publisher","first-page":"2234","DOI":"10.1001\/jama.2009.761","volume":"301","author":"RWJ Leunissen","year":"2009","unstructured":"Leunissen RWJ, Kerkhof GF, Stijnen T, Hokken-Koelega A. Timing and tempo of first-year rapid growth in relation to cardiovascular and metabolic risk profile in early adulthood. JAMA. 2009;301(21):2234\u201342.","journal-title":"JAMA"},{"key":"9154_CR38","doi-asserted-by":"crossref","unstructured":"Zhang DL, Du Q, Djemli A, Julien P, Fraser WD, Luo ZC. Early and late postnatal accelerated growth have distinct effects on metabolic health in normal birth weight infants. Front Endocrinol (Lausanne). 2017;8(DEC).","DOI":"10.3389\/fendo.2017.00340"},{"issue":"8","key":"9154_CR39","doi-asserted-by":"publisher","first-page":"1795","DOI":"10.2337\/dc12-0173","volume":"35","author":"CA Borgo\u00f1o","year":"2012","unstructured":"Borgo\u00f1o CA, Hamilton JK, Ye C, Hanley AJ, Connelly PW, Sermer M, et al. Determinants of insulin resistance in infants at age 1 year: impact of gestational diabetes mellitus. Diabetes Care. 2012Aug;35(8):1795\u20137.","journal-title":"Diabetes Care"},{"issue":"9254","key":"9154_CR40","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1016\/S0140-6736(00)04004-6","volume":"357","author":"A Singhal","year":"2001","unstructured":"Singhal A, Cole TJ, Lucas A. Early nutrition in preterm infants and later blood pressure: two cohorts after randomised trials. Lancet. 2001Feb 10;357(9254):413\u20139.","journal-title":"Lancet"},{"issue":"10","key":"9154_CR41","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1016\/S2213-8587(15)00219-3","volume":"3","author":"C Chiswick","year":"2015","unstructured":"Chiswick C, Reynolds RM, Denison F, Drake AJ, Forbes S, Newby DE, et al. Effect of metformin on maternal and fetal outcomes in obese pregnant women (EMPOWaR): a randomised, double-blind, placebo-controlled trial. Lancet Diabetes Endocrinol. 2015Oct 1;3(10):778\u201386.","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"7","key":"9154_CR42","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1007\/BF00400248","volume":"35","author":"CN Hales","year":"1992","unstructured":"Hales CN, Barker DJP. Type 2(non-insulin-dependent) diabetes mellitus: the thrifty phenotype hypothesis. Diabetologia. 1992;35(7):595\u2013601.","journal-title":"Diabetologia"},{"key":"9154_CR43","doi-asserted-by":"crossref","unstructured":"Kiserud T, Piaggio G, Carroli G, Widmer M, Carvalho J, Neerup Jensen L, et al. The World Health Organization fetal growth charts: a multinational longitudinal study of ultrasound biometric measurements and estimated fetal weight. PLoS Med. 2017;14(1).","DOI":"10.1371\/journal.pmed.1002220"},{"issue":"7","key":"9154_CR44","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1002\/jum.15224","volume":"39","author":"W Lee","year":"2020","unstructured":"Lee W, Mack LM, Sangi-Haghpeykar H, Gandhi R, Wu Q, Kang L, et al. Fetal weight estimation using automated fractional limb volume with 2-dimensional size parameters: a multicenter study. J Ultrasound Med. 2020Jul 1;39(7):1317\u201324.","journal-title":"J Ultrasound Med"},{"key":"9154_CR45","doi-asserted-by":"crossref","unstructured":"Teramo KA, Hiilesmaa VK, Schwartz R, Clemons GK, Widness JA. Amniotic fluid and cord plasma erythropoietin levels in pregnancies complicated by preeclampsia, pregnancy-induced hypertension and chronic hypertension. Vol. 32, J. Perinat. Med. 2004.","DOI":"10.1515\/JPM.2004.045"},{"issue":"10","key":"9154_CR46","doi-asserted-by":"publisher","first-page":"1695","DOI":"10.1007\/s00125-004-1515-3","volume":"47","author":"K Teramo","year":"2004","unstructured":"Teramo K, Kari MA, Eronen M, Markkanen H, Hiilesmaa V. High amniotic fluid erythropoietin levels are associated with an increased frequency of fetal and neonatal morbidity in type 1 diabetic pregnancies. Diabetologia. 2004;47(10):1695\u2013703.","journal-title":"Diabetologia"},{"issue":"7","key":"9154_CR47","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.7863\/ultra.16.03045","volume":"36","author":"LE Simcox","year":"2017","unstructured":"Simcox LE, Higgins LE, Myers JE, Johnstone ED. Intraexaminer and interexaminer variability in 3D fetal volume measurements during the second and third trimesters of pregnancy. J Ultrasound Med. 2017Jul 1;36(7):1415\u201329.","journal-title":"J Ultrasound Med"},{"issue":"4","key":"9154_CR48","doi-asserted-by":"publisher","first-page":"453.e1","DOI":"10.1016\/j.ajog.2017.06.018","volume":"217","author":"LE Simcox","year":"2017","unstructured":"Simcox LE, Myers JE, Cole TJ, Johnstone ED. Fractional fetal thigh volume in the prediction of normal and abnormal fetal growth during the third trimester of pregnancy. Am J Obstet Gynecol. 2017Oct 1;217(4):453.e1-453.e12.","journal-title":"Am J Obstet Gynecol"},{"issue":"1","key":"9154_CR49","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1210\/jc.2006-1071","volume":"92","author":"U Ekelund","year":"2007","unstructured":"Ekelund U, Ong KK, Linn\u00e9 Y, Neovius M, Brage S, Dunger DB, et al. Association of weight gain in infancy and early childhood with metabolic risk in young adults. J Clin Endocrinol Metab. 2007;92(1):98\u2013103.","journal-title":"J Clin Endocrinol Metab"},{"key":"9154_CR50","doi-asserted-by":"publisher","DOI":"10.1186\/1745-6215-15-139","author":"BC Kahan","year":"2014","unstructured":"Kahan BC, Jairath V, Dor\u00e9 CJ, Morris TP. The risks and rewards of covariate adjustment in randomized trials: an assessment of 12 outcomes from 8 studies. Trials. 2014. https:\/\/doi.org\/10.1186\/1745-6215-15-139.","journal-title":"Trials"}],"container-title":["Trials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-025-09154-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13063-025-09154-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-025-09154-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T13:21:53Z","timestamp":1760707313000},"score":1,"resource":{"primary":{"URL":"https:\/\/trialsjournal.biomedcentral.com\/articles\/10.1186\/s13063-025-09154-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,17]]},"references-count":50,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["9154"],"URL":"https:\/\/doi.org\/10.1186\/s13063-025-09154-5","relation":{},"ISSN":["1745-6215"],"issn-type":[{"value":"1745-6215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,17]]},"assertion":[{"value":"17 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"MIMICH has been approved by the London-Chelsea REC (REC reference 21\/LO\/0462) and HRA. Written, informed consent to participate is obtained from all participants and is obtained by an appropriately trained healthcare professional on the study team with delegated authority.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate {24}"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication {32}"}},{"value":"None.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests {28}"}}],"article-number":"423"}}